Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Olivier Tshiani-Mbaya"'
Autor:
Kasereka Masumbuko Claude, Daniel Mukadi-Bamuleka, Kitenge-Omasumbu Richard, Katsuva Mbahweka Francois, Paluku Mwalitsa Jean Paul, Kavugho Muliwavyo, François Edidi-Atani, Meris Matondo Kuamfumu, Sabue Mulangu, Olivier Tshiani-Mbaya, Placide Mbala-Kingebeni, Steve Ahuka-Mundeke, Jean-Jacques Muyembe-Tamfum, Bonita E. Lee, Stan Houston, Zubia Mumtaz, Michael T. Hawkes
Publikováno v:
EBioMedicine, Vol 106, Iss , Pp 105241- (2024)
Summary: Background: Ebola virus disease (EVD) is associated with multisystem organ failure and high mortality. Severe hypoglycaemia is common, life-threatening, and correctable in critically ill patients, but glucose monitoring may be limited in EVD
Externí odkaz:
https://doaj.org/article/65cc04a79c03439596b96243f3dae5f0
Autor:
Lindsey Kjaldgaard, Kasereka Masumbuko Claude, Daniel Mukadi-Bamuleka, Richard Kitenge-Omasumbu, Devika Dixit, François Edidi-Atani, Meris Matondo Kuamfumu, Junior Bulabula-Penge, Fabrice Mambu-Mbika, Olivier Tshiani-Mbaya, Janet Diaz, Sabue Mulangu, Anais Legand, Placide Mbala-Kingebeni, Pierre Formenty, Steve Ahuka-Mundeke, Jean-Jacques Muyembe-Tamfum, Michael T. Hawkes
Publikováno v:
EClinicalMedicine, Vol 53, Iss , Pp 101638- (2022)
Summary: Background: A paucity of data is available on virologic and biochemical characteristics of paediatric Ebolavirus disease (EVD), compared to adults. Methods: We conducted a retrospective chart review of children (7.6 log10copies/mL, alanine t
Externí odkaz:
https://doaj.org/article/cac8e90131de4e13ba663a81f3fec770
Autor:
Marie Jaspard, Sabue Mulangu, Sylvain Juchet, Beatrice Serra, Ibrahim Dicko, Hans-Joeg Lang, Baweye Mayoum Baka, Gaston Musemakweli Komanda, Jeremie Muhindo Katsavara, Patricia Kabuni, Fabrice Mbika Mambu, Margaux Isnard, Christophe Vanhecke, Alexia Letord, Ibrahima Dieye, Oscar Patterson-Lomba, Olivier Tshiani Mbaya, Fiston Isekusu, Donatien Mangala, Jean Luc Biampata, Richard Kitenge, Moumouni Kinda, Xavier Anglaret, Jean Jacques Muyembe, Richard Kojan, Khaled Ezzedine, Denis Malvy
Publikováno v:
EClinicalMedicine, Vol 54, Iss , Pp 101699- (2022)
Summary: Background: As mortality remains high for patients with Ebola virus disease (EVD) despite new treatment options, the ability to level up the provided supportive care and to predict the risk of death is of major importance. This analysis of t
Externí odkaz:
https://doaj.org/article/157912ca72314facb6b7ccc80da5c371
Autor:
Irini Sereti, Kathryn Shaw-Saliba, Lori E. Dodd, Robin L. Dewar, Sylvain Laverdure, Shawn Brown, Olivier Tshiani Mbaya, Jean Jacques Muyembe Tamfum, Placide Mblala-Kingebeni, Ydrissa Sow, Esther Akpa, Mory Cherif Haidara, Karine Fouth Tchos, Abdoul Habib Beavogui, Aaron Neal, Dona Arlinda, Dewi Lokida, Louis Grue, Mary Smolskis, Laura A. McNay, Dehkontee Gayedyu-Dennis, Guillermo M. Ruiz-Palacios, Abelardo Montenegro-Liendo, Moctar Tounkara, Seydou Samake, Ganbolor Jargalsaikhan, Delgersaikhan Zulkhuu, Shera Weyers, Tyler Bonnett, Gail E. Potter, Randy Stevens, Adam Rupert, Jamila Aboulhab, Jean-Luc Biampata, Alexandre Delamo, Bienvenu Salim Camara, Herman Kosasih Indonesia, Muhammad Karyana, James T. Duworko, Justino Regalado-Pineda, Paola del Carmen Guerra-de-Blas, Seydou Doumbia, Djeneba Dabitao, Naranjargal Dashdorj, Naranbaatar Dashdorj, Kevin Newell, Alyson Francis, Kevin Rubenstein, Victoria Bera, Iman Gulati, Ratna Sardana, Monica Millard, Renee Ridzon, Sally Hunsberger
Publikováno v:
PLoS ONE, Vol 17, Iss 9 (2022)
In response to the COVID-19 pandemic, COVID-19 vaccines have been developed, and the World Health Oraganization (WHO) has granted emergency use listing to multiple vaccines. Studies of vaccine immunogenicity data from implementing COVID-19 vaccines b
Externí odkaz:
https://doaj.org/article/35221598c0804d42bd34c327097f7182
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The unprecedented 2013-2016 West Africa Ebola outbreak accelerated several medical countermeasures (MCMs) against Ebola virus disease (EVD). Several investigational products (IPs) were used throughout the outbreak but were not conclusive for efficacy
Externí odkaz:
https://doaj.org/article/7582bc54c4a74357b16a1098efb3221d
Autor:
Olivier Tshiani Mbaya, Placide Mbala Kingebeni, Lori E Dodd, Jean-Jacques Muyembe Tamfum, Clifford Lane
Publikováno v:
The Lancet Infectious Diseases. 23:406-407
Autor:
Andrew J. McNeil, David W. House, Placide Mbala-Kingebeni, Olivier Tshiani Mbaya, Lori E. Dodd, Edward W. Cowen, Véronique Nussenblatt, Tyler Bonnett, Ziche Chen, Inga Saknite, Benoit M. Dawant, Eric R. Tkaczyk
Publikováno v:
Journal of Investigative Dermatology. 143:347-350.e4
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
The unprecedented 2013-2016 West Africa Ebola outbreak accelerated several medical countermeasures (MCMs) against Ebola virus disease (EVD). Several investigational products (IPs) were used throughout the outbreak but were not conclusive for efficacy
Autor:
Meng Shi, Jay W. Hooper, Nelson L. Michael, Shon Remich, James E. Moon, Judie B. Alimonti, Nicole M. Van Deusen, Paula Muñoz, Jocelyn Voell, Richard T. Davey, Barney S. Graham, Peter Silvera, Zonghui Hu, Linda L. Jagodzinski, H. Clifford Lane, Ramiro L. Gutierrez, Yan Zhou, Matthew D. Josleyn, Amy R. Castellano, John H. Beigel, Steven A. Kwilas, Patrick S. Twomey, Daphne A. Stanley, Kirsten S. Smith, Charles J. Link, Brian K. Martin, Kristopher M. Paolino, Wang Jing, W. Jay Ramsey, Holly R. Hack, Jason W. Bennett, Jason A. Regules, Olivier Tshiani Mbaya, Richard C. Ruck, Sheila A. Peel, Stephen J. Thomas, Nancy J. Sullivan, Julie E. Ledgerwood, Thomas P. Monath, Meagan L. Wisniewski
Publikováno v:
New England Journal of Medicine. 376:330-341
The worst Ebola virus disease (EVD) outbreak in history has resulted in more than 28,000 cases and 11,000 deaths. We present the final results of two phase 1 trials of an attenuated, replication-competent, recombinant vesicular stomatitis virus (rVSV
Autor:
Sabue, Mulangu, Lori E, Dodd, Richard T, Davey, Olivier, Tshiani Mbaya, Michael, Proschan, Daniel, Mukadi, Mariano, Lusakibanza Manzo, Didier, Nzolo, Antoine, Tshomba Oloma, Augustin, Ibanda, Rosine, Ali, Sinaré, Coulibaly, Adam C, Levine, Rebecca, Grais, Janet, Diaz, H Clifford, Lane, Jean-Jacques, Muyembe-Tamfum, Billy, Sivahera, Modet, Camara, Richard, Kojan, Robert, Walker, Bonnie, Dighero-Kemp, Huyen, Cao, Philippe, Mukumbayi, Placide, Mbala-Kingebeni, Steve, Ahuka, Sarah, Albert, Tyler, Bonnett, Ian, Crozier, Michael, Duvenhage, Calvin, Proffitt, Marc, Teitelbaum, Thomas, Moench, Jamila, Aboulhab, Kevin, Barrett, Kelly, Cahill, Katherine, Cone, Risa, Eckes, Lisa, Hensley, Betsey, Herpin, Elizabeth, Higgs, Julie, Ledgerwood, Jerome, Pierson, Mary, Smolskis, Ydrissa, Sow, John, Tierney, Sumathi, Sivapalasingam, Wendy, Holman, Nikki, Gettinger, David, Vallée, Jacqueline, Nordwall, Marie Claire, Kolie
Publikováno v:
The New England journal of medicine. 381(24)
Although several experimental therapeutics for Ebola virus disease (EVD) have been developed, the safety and efficacy of the most promising therapies need to be assessed in the context of a randomized, controlled trial.We conducted a trial of four in